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Acute effects of a guided relaxation routine (body scan) on tobacco withdrawal 
symptoms and cravings in abstinent smokers 
 
Aims To examine the acute effects of a guided relaxation routine (body scan) on 
desire to smoke and tobacco withdrawal symptoms in overnight abstinent smokers. 
Design Experimental. 
Participants Thirty individuals reporting to smoke 10 or more cigarettes daily for at 
least three years. 
Intervention Participants were randomly assigned to complete a 10 minute body 
scan (experimental group n = 15) or listen to a natural history passage for 10 minutes 
(control group n = 15).  
Measurement Ratings of strength of desire to smoke and smoking withdrawal 
symptoms were assessed at baseline, immediately after the interventions, and 5, 10 & 
15 minutes post-intervention.  
Findings There was a significant group by time interaction for strength of desire to 
smoke. The mean desire to smoke rating was significantly lower in the body scan 
group relative to the control group immediately after the intervention, and 5 minutes 
post intervention. The body scan group also reported lower ratings of irritability, 
tension, and restlessness, relative to the controls.  
Conclusion A brief body scan intervention reduces strength of desire to smoke and 
some tobacco withdrawal symptoms in temporarily abstaining smokers. The body 
scan may be beneficial as a technique for managing cigarette cravings and 
withdrawal.  
 
Keywords smoking cessation, body scan, mindfulness, withdrawal 
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INTRODUCTION 
Severe cravings for cigarettes are a reliable predictor of smoking relapse (1). Nicotine 
replacement therapy (NRT) and bupropion have been shown to be two of the most 
effective aids to smoking cessation (2;3) and these therapies are thought to work 
largely through moderating cigarette cravings and withdrawal symptoms. Laboratory 
studies have shown that non-pharmaceutical interventions; for example, 
cardiovascular exercise (4) and glucose consumption (5), can also be effective for 
reducing cigarette cravings and withdrawal symptoms. However, exercise is 
impractical in many situations and glucose consumption may not be appropriate for 
some individuals (e.g., diabetics). Further behavioural and cognitive strategies, that 
are appealing to the majority of smokers, need to be developed for managing cigarette 
cravings.  
 Stress is likely to exacerbate the desire to smoke, to motivate smoking, and stress 
has been associated with smoking relapse (6-9). Stress reduction techniques may 
therefore be effective for managing cravings. One stress management technique that 
has been attracting research attention is mindfulness (10). Mindfulness emphasises the 
focussing of attention on the present, without questioning or being judgemental of the 
information that comes to mind. Mindfulness techniques have been incorporated in 
many clinical programmes and practising mindfulness has been shown to improve the 
quality of life in patients within a variety of clinical and non-clinical issues (11). 
 One aspect of mindfulness, which is the focus of the present study, is the 'body 
scan’. Body scan is a cognitive relaxation technique that requires individuals to move 
their focus of attention around different parts of their body. The individual first 
concentrates on observing their breathing, before moving their awareness to other 
body regions. Body scan has been found to be an effective stress management 
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technique (10), and is therefore likely to have beneficial effects for reducing the urge 
to smoke. Body scan is relatively easy to learn, it can be used in a wide variety of 
situations and it may be particularly attractive among those smokers who cannot, or 
who choose not to, use NRT products, e.g. pregnant women, or those adverse to 
exercise or glucose.  
 A previous study observed no effect of a body scan on desire to smoke and 
withdrawal symptoms, compared with a passive control condition (12). However, in 
this study the participants were not guided through the body scan, as is generally 
advised. Therefore, the present study assessed the effects of a guided body scan, 
versus a neutral audio recording, on ratings of desire to smoke and cigarette 
withdrawal symptoms among smokers who abstained from smoking overnight. It was 
hypothesised that those undergoing the body scan would report a significant reduction 
in desire to smoke and cigarette withdrawal symptoms, relative to those in the control 
group.  
 
METHOD 
Participants 
The sample included 18 men and 12 women aged 21 – 31 years (Mean (SD) =25.5 
(2.9) years), smoking at least 10 cigarettes per day for at least three consecutive years. 
Participants were recruited via posters, within the campus of the University of Surrey.   
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Materials  
Body scan  
Typically, a body scan takes 30-45 minutes; however, for the purpose of the study a 
10-minute version was developed, as this would be more appealing and practical for 
the majority of smokers. Once comfortable, individuals were asked to follow an audio 
recording of a guided body scan. First, they were instructed to focus on their breathing 
by concentrating attention on their abdominal area. Focus of awareness was then 
gradually moved to other areas of the body.  
Control  
The control condition involved participants listening to a 10-minute audio recording 
of a natural history text (13). Individuals who listened to a pilot audio reported this to 
be a neutral, but relaxing passage. Pauses within both recordings were made in 
approximately the same place. For both conditions, audio instructions were presented 
via headphones. A copy of the two recordings is available from the corresponding 
author.  
Measures 
Background measures covered smoking characteristics, including the Fagerström Test 
for Nicotine Dependence (FTND) (14) and demographic details. The FTND was used 
to assess self-reported dependency levels between the body scan and control 
participants. This is a widely used and valid measure of nicotine dependence (15). 
Seven cigarette withdrawal symptoms were assessed using the Mood and Physical 
Symptoms Scale (MPSS) (16). These were strength of desire to smoke, irritability, 
tension, depression, restlessness, difficulty concentrating, and stress. Each was rated 
on a 7 – point scale, for example, ‘How strong is your desire to smoke right now?’ or 
‘How tense to you feel right now?’ (1 = not at all, 4 = somewhat,  7 = extremely). The 
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MPSS has been widely used to access transient shifts in cigarette withdrawal 
symptoms and has good psychometric properties (17;18).   
 
Procedure  
Volunteers were initially screened for carbon monoxide (CO) levels to confirm 
smoking status (all individuals reported CO concentrations >15ppm) and completed 
background measures. Following overnight abstinence, each individual attended a 
laboratory testing session between 12 noon and 2pm. On entering the laboratory 
individuals were seated and their baseline CO concentrations were assessed to 
confirm smoking abstinence (<10ppm). Next, they gave baseline ratings for 
withdrawal symptoms and desire to smoke using the MPSS. Participants were then 
randomly assigned to either the body scan or control condition. Further ratings of the 
MPSS were taken immediately after the interventions, and at five, 10 and 15 minutes 
post-intervention. 
RESULTS  
 
There was no significant difference between the two groups for any of the 
demographic or smoking characteristics (Table 1) or any of the baseline MPSS items.  
For each MPSS item, baseline ratings were subtracted from ratings taken immediately 
after the intervention and at, five, 10 and 15 minutes post-intervention. Depression, 
irritability and stress, had very low baseline ratings and were therefore excluded from 
further analysis. Means and SD for all the MPSS items are available from either 
author. The remaining data was analysed using a series of group (body scan/control) 
by time (0, 5, 10, 15 minutes post-intervention) repeated measures Analysis of 
Variance (ANOVA). Where the overall group by time interaction was significant, 
planned comparisons were calculated for baseline versus each further time point. For 
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ease of understanding, means and the results of the ANOVA, plus effect size (partial 
eta2) for all smoking withdrawal items are presented in Figure 1. 
There were significant main group effects for irritability, tension, and 
restlessness. In all cases the body scan group gave a lower rating relative to the 
controls: Irritability (Mean -1.63 vs. -0.15); tension (Mean -2.01 vs. - 0.58), and 
restlessness (Mean -1.28 vs. -0.51). There was as expected a significant effect of time 
for strength of desire to smoke, irritability, tension, and restlessness. There was a 
significant group by time interaction for strength of desire to smoke. The mean 
strength of desire to smoke rating was 1 point lower (on a 7 point scale) in the body 
scan group relative to the control group immediately after the intervention, and 0.93 
points lower at 5 minutes (P < 0.05). There was no significant group by time 
interaction for irritability, restlessness or tension.  
 
DISCUSSION 
This study examined the effects of a brief body scan following overnight abstinence 
from smoking. Relative to baseline, strength of desire to smoke was reduced up to 
five minutes following the 10-minute body scan, compared with the control condition. 
This effect is modest, and requires replication but indicates that a brief body scan has 
the potential to provide relief for smokers experiencing severe cigarette cravings 
during smoking abstinence. The laboratory is an artificial setting for smokers and the 
effects of the body scan on smoking cravings may not be as powerful in this 
environment as it is in the real world. In the laboratory participants are required to sit 
quietly and do nothing between the rating periods whereas in daily life smokers would 
be able to distract themselves from their cravings by doing other things e.g., working.  
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The body scan also showed benefits for moderating feelings of irritability, tension and 
restlessness that are common symptoms during smoking withdrawal. Therefore, the 
body scan may have broader benefits beyond the management of cigarette cravings. 
Overall these findings are comparable to other studies that have used similar 
methodology (19;20). For example, Daniel et al. (19) reported a reduction from 
baseline of 1.5 in ratings of ‘strength of desire to smoke’ following 10 minutes of 
moderate intensity exercise, and a reduction of approximately 1.5 for irritability, 
tension and restlessness, in the laboratory for smokers who had abstained from 
smoking between 11-15 hours.  
The body scan could be readily incorporated into behaviorally-based stop 
smoking programmes or could be utilized by individuals who choose not to use 
professional smoking cessation services. The body scan does not need to be 
performed in a seated position and with practice the technique can be used without an 
audio aid. Therefore the body scan is potentially beneficial across the large majority 
of smokers; including those who are contraindicated for pharmaceutical aids or who 
prefer not to use such products (e.g. pregnant smokers).  
It was beyond the scope of this study to investigate the mechanisms involved; 
however, it is possible that the effect of body scan was partly the result of distraction 
and could also be due to stress reduction effects. As reported above, stress has been 
shown to affect cigarette withdrawal symptoms and we expected participants in the 
body scan condition to report lower ratings of stress following the intervention. 
Unfortunately, due to low baseline ratings from both groups it was not possible to 
assess whether the intervention did indeed affect stress. We did nevertheless; find a 
greater reduction in tension, restlessness and irritability, which may be considered 
manifestations of stress, for the body scan group relative to the controls. Further 
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studies are needed to explore mechanisms; for example, through using 
psychophysiological measures such as EEG and cortisol. In addition, research is 
needed to assess the benefits of the body scan when high levels of stress are reported. 
Studies are also needed in order to assess how body scan interacts with the effects of 
NRT; for example, does body scan have an additive or synergistic effect when 
combined with NRT? In addition, work is needed to compare the body scan with other 
stress management techniques; for example, with different deep breathing exercises. 
Finally, this study was limited to temporarily abstinent smokers in a laboratory setting 
and research is required to explore whether the technique is similarly effective outside 
the laboratory, or during an actual quit attempt and with repeated usage. 
Notwithstanding, the present results suggest that training individuals to use the body 
scan relaxation technique might be beneficial for some people as a strategy for 
managing the urge to smoke. 
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Table 1 Mean (± SD) demographic and smoking characteristics for the control and 
body scan groups  
 
 Control Body Scan 
Age 25.6 ± 2.3 25.3 ± 3.6 
Years smoking 7.3 ± 3.0 7.0 ± 2.4 
Cigarettes smoked per day 16.3 + 3.3 19.6 ± 5.5 
FTND 4.5 ± 1.3 5.0 ± 1.8 
ECO following overnight abstinence 5.0 ± 1.5 5.9 ± 2.0 
Hours abstained  12.5 ± 0.7 13.1 ± 1.2 
 
FTND = Fagerström Test for Nicotine Dependence, ECO = expired carbon monoxide.  
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Figure 1 (a-d). Ratings of MPSS withdrawal symptoms for the body scan and the 
control groups (baseline ratings subtracted from ratings taken immediately after 
intervention (0) and 5, 10 and 15 minutes post-intervention). 
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 Group main effect (F=2.12, p = 0.15), ES = .07.  Group main effect (F=9.15, p< 0.005, ES = .24.  
 Time main effect (F=36.10, p< 0.001), ES = .54.  Time main effect (F=35.89, p< 0.001), ES = .56.  
 Group x Time (F=8.27, p< 0.001), ES = .28.  Group x Time (F=0.02, p = 0.83), ES = .01. 
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  Group main effect (F=4.10, p< 0.05, ES = .12.  Group main effect (F=9.55, p< 0.005), ES = .25.  
  Time main effect (F=22.85, p< 0.001), ES = .49. Time main effect (F=11.72, p< 0.001), ES = .29.  
  Group x Time (F=0.61, p = 0.54), ES = .02.  Group x Time (F=1.88, p = 0.13), ES = .06.  
 
 
ES = Effect Size 
